Shares of Stratec SE (ETR:SBS – Get Free Report) were up 0.8% during mid-day trading on Friday. The company traded as high as €24.40 and last traded at €24.20. Approximately 6,738 shares changed hands during mid-day trading, an increase of 8% from the average session volume of 6,253 shares. The stock had previously closed at €24.00.
Stratec Price Performance
The firm has a market capitalization of $290.73 million, a P/E ratio of 29.04, a price-to-earnings-growth ratio of 10.43 and a beta of 0.84. The company has a debt-to-equity ratio of 48.53, a quick ratio of 1.65 and a current ratio of 4.23. The business has a 50 day simple moving average of €22.97 and a two-hundred day simple moving average of €19.82.
Stratec Company Profile
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018.
See Also
- Five stocks we like better than Stratec
- Bank of America Stock Sell-Off Looks Like a Buying Opportunity
- AST SpaceMobile Is Down 67%—Could SpaceX’s Mobile Push Deepen the Selloff?
- GlobalFoundries’ $21 Billion Deal Could Change the Economics of Chipmaking
- Fundamental and Technicals Signals Align for Costco: Is the Stock Finally Breaking Out?
Receive News & Ratings for Stratec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stratec and related companies with MarketBeat.com's FREE daily email newsletter.
